Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: A randomized controlled trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20160209001

Enrollment

Unknown

Registered

2016-02-09

Start date

2013-08-02

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal tunnel syndrome Carpal tunnel syndrome

Interventions

Patients recieved 1. commercial adjustable wrist splint that set wrist joint at neutral (sero degree) 2. Patient instruction regarding improper positions and/or activities to avoid 3. Low&#45

dose vitamin B6 (15mg per day),Patients in control group recieved 1)Patient instruction regarding improper positions and/or activities to avoid 2) Low&#45

dose vitamin B6 (15mg per day)

Experimental Device,Active Comparator Other

Splinting,Control

Eligibility

Sex/Gender

All

Age

30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who 1. had symptoms and physical examination associated with CTS 2. had a nerve conduction study of mild to moderate CTS 3. were willing to join the study

Exclusion criteria

Exclusion criteria: 1) CTS previously treated with steroid injection or surgery; 2) history of hand or wrist injury; 3) diagnosed as cervical radiculopathy or peripheral neuropathy; 4) underlying disorders resulting from poorly controlled DM; 5) pregnancy; and 6) other metabolic diseases.

Design outcomes

Primary

Measure	Time frame
Neurophysiologic condition 3 months after intervention Nerve conduction study	—

Secondary

Measure	Time frame
Symptoms and functional status 3 months after intervention Boston Carpal Tunnel Questionnaire	—

Countries

Thailand

Contacts

Public ContactJariya Boonhong

Faculty of Medicine, Chulalongkorn University

jariya_boonhong@yahoo.com+66818891355

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Three&#45;month neutral wrist splint in mild to moderate carpal tunnel syndrome: A randomized controlled trial